Subscribe to RSS
DOI: 10.1055/a-1159-0644
Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer
![](https://www.thieme-connect.de/media/endoscopy/202010/lookinside/thumbnails/18655_10-1055-a-1159-0644-1.jpg)
Abstract
Background Colorectal cancer (CRC) screening programs based on fecal immunochemical testing (FIT) generate substantial pressure on colonoscopy capacity in Europe. Thus, a relevant proportion of FIT-positive patients undergo colonoscopy after the recommended 30-day interval, which may be associated with an excess CRC risk.
Methods In a cohort of 50–69-year-old patients undergoing biennial rounds of FIT (OC-Hemodia latex agglutination test; cutoff 20 µg hemoglobin/g feces) between 2004 and 2017, we assessed the outcome at colonoscopy (low/high risk adenoma/CRC/advanced stage CRC) among FIT-positive patients, according to different time intervals. The association of each outcome with waiting time, and demographic and clinical factors, was analyzed through multivariable analysis.
Results 123 138/154 213 FIT-positive patients (79.8 %) underwent post-FIT colonoscopy. Time to colonoscopy was ≤ 30 days, 31–180 days, and ≥ 181 days in 50 406 (40.9 %), 71 724 (58.3 %), and 1008 (0.8 %) patients, respectively. At colonoscopy, CRC, high risk adenoma, and low risk adenoma were diagnosed in 4813 (3.9 %), 30 500 (24.8 %), and 22 986 (18.7 %) patients, respectively. An increased CRC prevalence at colonoscopy was observed for a time to colonoscopy of ≥ 270 days (odds ratio [OR] 1.75, 95 % confidence interval [CI] 1.15–2.67), whereas it was stable for waiting times of < 180 days. The proportion of advanced CRC also increased after 270 days (OR 2.79, 95 %CI 1.03–7.57). No increase for low or high risk adenomas according to time to colonoscopy was observed.
Conclusion In a European FIT-based screening program, post-FIT colonoscopy after 9 months was associated with an increased risk of CRC and CRC progression.
Publication History
Received: 27 December 2019
Accepted: 30 March 2020
Article published online:
30 April 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Chambers K, Whiteman K, Stephens K. et al. Improving inpatient colonoscopy preparation in a university hospital: an evidence-based practice project. Gastroenterol Nurs 2016; 39: 86-94
- 2 Moss S, Mathews C, Day TJ. et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut 2017; 66: 1631-1644
- 3 Hol L, van Leerdam ME, van Ballegooijen M. et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-68
- 4 Zorzi M, Fedato C, Grazzini G. et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-949
- 5 Zorzi M, Fedeli U, Schievano E. et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2015; 64: 784-790
- 6 Zorzi M, Hassan C, Capodaglio G. et al. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Gut 2018; 67: 2124-2130
- 7 Zorzi M, Zappa M, AIRTUM WorkingGroup. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates. Gut 2020; 69: 311-316
- 8 Senore C, Basu P, Anttila A. et al. Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut 2019; 68: 1232-1244
- 9 Corley DA, Jensen CD, Quinn VP. et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA 2017; 317: 1631-1641
- 10 Meester RGS, Zauber AG, Doubeni CA. et al. Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test. Clin Gastroenterol Hepatol 2016; 14: 1445-1451.e8
- 11 Lee Y-C, Fann JC-Y, Chiang T-H. et al. Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests. Clin Gastroenterol Hepatol 2019; 17: 1332-1340.e3
- 12 Beshara A, Ahoroni M, Comanester D. et al. Association between time to colonoscopy after a positive guaiac fecal test result and risk of colorectal cancer and advanced stage disease at diagnosis. Int J Cancer 2020; 146: 1532-1540
- 13 European Colorectal Cancer Screening Guidelines Working Group. . European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51-59
- 14 Zorzi M, Barca A, Falcini F. et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev 2007; 31: 49-60
- 15 Brenner H, Altenhofen L, Stock C. et al. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev 2013; 22: 1043-1051